Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
This study is ongoing, but not recruiting participants.
Study NCT00006734 Information provided by National Cancer Institute (NCI)
First Received: December 6, 2000 Last Updated: April 15, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma
Additional conditions recognized in this trial
Neuroectodermal Tumors
Sarcoma, Ewing's
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Osteosarcoma
Interventions listed in this trial
filgrastim
cyclophosphamide
doxorubicin hydrochloride
etoposide
ifosfamide
vincristine sulfate
adjuvant therapy
conventional surgery
neoadjuvant therapy
brachytherapy
radiation therapy
Additional drug interventions recognized in this trial
Doxorubicin
Vincristine
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)
Southwest Oncology Group
Back to top of Main Content
